View in EDS

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Authors: Borghaei H; Fox Chase Cancer Center, Philadelphia, PA., Gettinger S; Yale Comprehensive Cancer Center, New Haven, CT., Vokes EE; Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL., Chow LQM; University of Washington, Seattle Cancer Care Alliance, Seattle, WA., Burgio MA; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., de Castro Carpeno J; Hospital De Madrid, Norte Sanchinarro, Madrid, Spain., Pluzanski A; Maria Sklodowska-Curie Inst of Oncology, Warsaw, Poland., Arrieta O; Instituto Nacional De Cancerología, Mexico City, Mexico., Frontera OA; Centro de Investigación Clínica Bradford Hill and Centro Internacional de Estudios Clinicos, Santiago, Chile., Chiari R; Ospedale S. Maria Della Misericordia, Perugia, Italy., Butts C; Cross Cancer Institute, Edmonton, AB, Canada., Wójcik-Tomaszewska J; Provincial Center of Oncology in Gdańsk, Gdańsk, Poland., Coudert B; Centre Georges-François Leclerc, Dijon, France., Garassino MC; Instituto Nazionale per Lo Studio e La Cura, Milano, Italy., Ready N; Duke University Medical Center, Durham, NC., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., García MA; Hospital Universitario Virgen Del Rocio, Sevilla, Spain., Waterhouse D; Oncology Hematology Care, Inc, Cincinnati, OH., Domine M; Fundacion Jimenez Diaz, IIS-FJD Madrid, Spain., Barlesi F; Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France., Antonia S; H. Lee Moffitt Cancer Center, Tampa, FL., Wohlleber M; Robert Bosch Cancer Center, Gerlingen, Germany., Gerber DE; UT Southwestern Medical Center, Dallas, TX., Czyzewicz G; John Paul II Hospital, Kraków, Poland., Spigel DR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN., Crino L; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Eberhardt WEE; Universitaetsmedizin Essen und Ruhrlandklinik, Essen, Germany., Li A; Bristol Myers Squibb, Princeton, NJ., Marimuthu S; Bristol Myers Squibb, Princeton, NJ., Brahmer J; Johns Hopkins Kimmel Cancer Center, Baltimore, MD.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Mar 01; Vol. 39 (7), pp. 723-733. Date of Electronic Publication: 2021 Jan 15.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33449799
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Borghaei+H%22">Borghaei H</searchLink>; Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Gettinger+S%22">Gettinger S</searchLink>; Yale Comprehensive Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Vokes+EE%22">Vokes EE</searchLink>; Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Chow+LQM%22">Chow LQM</searchLink>; University of Washington, Seattle Cancer Care Alliance, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Burgio+MA%22">Burgio MA</searchLink>; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22de+Castro+Carpeno+J%22">de Castro Carpeno J</searchLink>; Hospital De Madrid, Norte Sanchinarro, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pluzanski+A%22">Pluzanski A</searchLink>; Maria Sklodowska-Curie Inst of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Arrieta+O%22">Arrieta O</searchLink>; Instituto Nacional De Cancerología, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Frontera+OA%22">Frontera OA</searchLink>; Centro de Investigación Clínica Bradford Hill and Centro Internacional de Estudios Clinicos, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Chiari+R%22">Chiari R</searchLink>; Ospedale S. Maria Della Misericordia, Perugia, Italy.<br /><searchLink fieldCode="AU" term="%22Butts+C%22">Butts C</searchLink>; Cross Cancer Institute, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Wójcik-Tomaszewska+J%22">Wójcik-Tomaszewska J</searchLink>; Provincial Center of Oncology in Gdańsk, Gdańsk, Poland.<br /><searchLink fieldCode="AU" term="%22Coudert+B%22">Coudert B</searchLink>; Centre Georges-François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Garassino+MC%22">Garassino MC</searchLink>; Instituto Nazionale per Lo Studio e La Cura, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Ready+N%22">Ready N</searchLink>; Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Felip+E%22">Felip E</searchLink>; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García+MA%22">García MA</searchLink>; Hospital Universitario Virgen Del Rocio, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Waterhouse+D%22">Waterhouse D</searchLink>; Oncology Hematology Care, Inc, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Domine+M%22">Domine M</searchLink>; Fundacion Jimenez Diaz, IIS-FJD Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Barlesi+F%22">Barlesi F</searchLink>; Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Antonia+S%22">Antonia S</searchLink>; H. Lee Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Wohlleber+M%22">Wohlleber M</searchLink>; Robert Bosch Cancer Center, Gerlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gerber+DE%22">Gerber DE</searchLink>; UT Southwestern Medical Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Czyzewicz+G%22">Czyzewicz G</searchLink>; John Paul II Hospital, Kraków, Poland.<br /><searchLink fieldCode="AU" term="%22Spigel+DR%22">Spigel DR</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22Crino+L%22">Crino L</searchLink>; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Eberhardt+WEE%22">Eberhardt WEE</searchLink>; Universitaetsmedizin Essen und Ruhrlandklinik, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Li+A%22">Li A</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Marimuthu+S%22">Marimuthu S</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Brahmer+J%22">Brahmer J</searchLink>; Johns Hopkins Kimmel Cancer Center, Baltimore, MD.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2021 Mar 01; Vol. 39 (7), pp. 723-733. <i>Date of Electronic Publication: </i>2021 Jan 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33449799
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.20.01605
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 723
    Titles:
      – TitleFull: Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Borghaei H
      – PersonEntity:
          Name:
            NameFull: Gettinger S
      – PersonEntity:
          Name:
            NameFull: Vokes EE
      – PersonEntity:
          Name:
            NameFull: Chow LQM
      – PersonEntity:
          Name:
            NameFull: Burgio MA
      – PersonEntity:
          Name:
            NameFull: de Castro Carpeno J
      – PersonEntity:
          Name:
            NameFull: Pluzanski A
      – PersonEntity:
          Name:
            NameFull: Arrieta O
      – PersonEntity:
          Name:
            NameFull: Frontera OA
      – PersonEntity:
          Name:
            NameFull: Chiari R
      – PersonEntity:
          Name:
            NameFull: Butts C
      – PersonEntity:
          Name:
            NameFull: Wójcik-Tomaszewska J
      – PersonEntity:
          Name:
            NameFull: Coudert B
      – PersonEntity:
          Name:
            NameFull: Garassino MC
      – PersonEntity:
          Name:
            NameFull: Ready N
      – PersonEntity:
          Name:
            NameFull: Felip E
      – PersonEntity:
          Name:
            NameFull: García MA
      – PersonEntity:
          Name:
            NameFull: Waterhouse D
      – PersonEntity:
          Name:
            NameFull: Domine M
      – PersonEntity:
          Name:
            NameFull: Barlesi F
      – PersonEntity:
          Name:
            NameFull: Antonia S
      – PersonEntity:
          Name:
            NameFull: Wohlleber M
      – PersonEntity:
          Name:
            NameFull: Gerber DE
      – PersonEntity:
          Name:
            NameFull: Czyzewicz G
      – PersonEntity:
          Name:
            NameFull: Spigel DR
      – PersonEntity:
          Name:
            NameFull: Crino L
      – PersonEntity:
          Name:
            NameFull: Eberhardt WEE
      – PersonEntity:
          Name:
            NameFull: Li A
      – PersonEntity:
          Name:
            NameFull: Marimuthu S
      – PersonEntity:
          Name:
            NameFull: Brahmer J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2021 Mar 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1